drugset / Trial / NCT01924052

CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load

NCT01924052

Completed 40 enrolled Danish Headache Center
Non-randomizedParallel-groupDouble-blindOther

Summary

The investigators hypothesized that migraine without patients with many genetic loci associated with migraine (high genetic load) would be more sensitive and get provoked more migraine attacks by calcitonin gene-related peptide (CGRP) compared to patients with few genetic loci associated with migraine (low genetic load).

Timeline

Start
2013-06
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcitonin Gene-Related Peptide Peptide 1.5 ug Intravenous

Indications